Welcome to another episode of Biotechnology Focus radio!
This week Toronto got their socks knocked off by an announcement from Sanofi; a Chinese company expresses interest in some of Canada’s regenerative medicine technologies; the scope of clinical trials in Canada is divulged at the recent Clinical Trials Ontario conference; and Shana Kelley and her team from the University of Toronto use new technology to essentially ‘find a needle in a haystack’ when it comes to prostate cancer.
Keep listening to hear the latest news of Canada’s biotech scene!
Oncolytic virotherapy: unleashing anti-tumour immunity Next Post:
Post-antibiotic apocalypse with the ‘Superbug’